Straumann rises after Q3 sales modestly beat expectations

By Reuters News

** Shares in Swiss dental implants maker Straumann STMN.S rise 2.7% in pre-market indications after Q3 revenue slightly beat expectations driven by all regions

** The company reported Q3 revenue of 667.1 million Swiss francs ($805.1 million) versus a Vara consensus of 662.3 million

** North America sales grew 7.5%, with the broker Vontobel saying the region "performed as expected" and continued its positive trajectory despite a soft demand backdrop

** The group confirmed its full-year outlook

** The stock has gained 4.5% YTD

($1 = 0.8286 Swiss francs)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.